MicroRNA-145 suppresses ROS-induced Ca2+ overload of cardiomyocytes by targeting CaMKIIδ

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 720-726

  Cha, Min Ji ^a   Jang, Jin Kyung ^e   Ham, Onju ^a   Song, Byeong Wook ^a   Lee, Se Yeon ^a   Lee, Chang Yeon ^b   Park, Jun Hee ^b   Lee, Jiyun ^a   Seo, Hyang Hee ^a   Choi, Eunhyun ^c   Jeon, Woo min ^d   Hwang, Hye Jin ^a   Shin, Hyun Taek ^e   Choi, Eunmi ^a   Hwang, Ki Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Sahmyook University   (South Korea)

^e Sookmyung Women's University   (South Korea)

Author keywords

Apoptosis; Calcium overload; Calcium calmodulin dependent protein kinase II ; Cardiomyocytes; MicroRNA 145

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA; CALCIUM ION; HYDROGEN PEROXIDE; MICRORNA; MICRORNA 145; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE CONTROL; HEART MUSCLE CELL; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION;

ANIMALS; ANIMALS, NEWBORN; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELLS, CULTURED; HYDROGEN PEROXIDE; MICRORNAS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 84878991282     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.050     Document Type: Article

References (30)

1. Sorescu D., Griendling K.K. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest. Heart Fail. 2002, 8:132-140.
2. Yang Y., Zhu W.Z., Joiner M.L., Zhang R., Oddis C.V., Hou Y., Yang J., Price E.E., Gleaves L., Eren M., Ni G., Vaughan D.E., Xiao R.P., Anderson M.E. Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H3065-H3075.
3. Vila-Petroff M., Salas M.A., Said M., Valverde C.A., Sapia L., Portiansky E., Hajjar R.J., Kranias E.G., Mundina-Weilenmann C., Mattiazzi A. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc. Res. 2007, 73:689-698.
4. Yoo B., Lemaire A., Mangmool S., Wolf M.J., Curcio A., Mao L., Rockman H.A. Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1377-H1386.
5. Zhang T., Brown J.H. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc. Res. 2004, 63:476-486.
6. Singh M.V., Anderson M.E. Is CaMKII a link between inflammation and hypertrophy in heart?. J. Mol. Med. (Berlin) 2011, 89:537-543.
7. Singh M.V., Swaminathan P.D., Luczak E.D., Kutschke W., Weiss R.M., Anderson M.E. MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. J. Mol. Cell. Cardiol. 2012, 52:1135-1144.
8. Kim J.B., Kim C., Choi E., Park S., Park H., Pak H.N., Lee M.H., Shin D.C., Hwang K.C., Joung B. Particulate air pollution induces arrhythmia via oxidative stress and calcium calmodulin kinase II activation. Toxicol. Appl. Pharmacol. 2012, 259:66-73.
9. Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123:631-640.
10. Shukla G.C., Singh J., Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell Pharmacol. 2011, 3:83-92.
11. Latronico M.V., Condorelli G. MicroRNAs and cardiac pathology. Nat. Rev. Cardiol. 2009, 6:419-429.
12. Scalbert E., Bril A. Implication of microRNAs in the cardiovascular system. Curr. Opin. Pharmacol. 2008, 8:181-188.
13. Li P. MicroRNAs in cardiac apoptosis. J. Cardiovasc. Transl. Res. 2010, 3:219-224.
14. Yu X.Y., Song Y.H., Geng Y.J., Lin Q.X., Shan Z.X., Lin S.G., Li Y. Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochem. Biophys. Res. Commun. 2008, 376:548-552.
15. Tang Y., Zheng J., Sun Y., Wu Z., Liu Z., Huang G. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int. Heart J. 2009, 50:377-387.
16. Shan Z.X., Lin Q.X., Deng C.Y., Zhu J.N., Mai L.P., Liu J.L., Fu Y.H., Liu X.Y., Li Y.X., Zhang Y.Y., Lin S.G., Yu X.Y. MiR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS Lett. 2010, 584:3592-3600.
17. He B., Xiao J., Ren A.J., Zhang Y.F., Zhang H., Chen M., Xie B., Gao X.G., Wang Y.W. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J. Biomed. Sci. 2011, 18:22.
18. Zhu H., Yang Y., Wang Y., Li J., Schiller P.W., Peng T. MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc. Res. 2011, 92:75-84.
19. Zhang C. MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease. Cell Cycle 2009, 8:3469-3473.
20. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.H., Miano J.M., Ivey K.N., Srivastava D. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
21. Turczynska K.M., Sadegh M.K., Hellstrand P., Sward K., Albinsson S. MicroRNAs are essential for stretch-induced vascular smooth muscle contractile differentiation via microRNA (miR)-145-dependent expression of L-type calcium channels. J. Biol. Chem. 2012, 287:19199-19206.
22. Xu Q., Liu L.Z., Qian X., Chen Q., Jiang Y., Li D., Lai L., Jiang B.H. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res. 2012, 40:761-774.
23. Cho W.C., Chow A.S., Au J.S. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol. 2011, 8:125-131.
24. Wang S., Bian C., Yang Z., Bo Y., Li J., Zeng L., Zhou H., Zhao R.C. MiR-145 inhibits breast cancer cell growth through RTKN. Int. J. Oncol. 2009, 34:1461-1466.
25. Hori M., Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc. Res. 2009, 81:457-464.
26. Garcia-Dorado D., Ruiz-Meana M., Inserte J., Rodriguez-Sinovas A., Piper H.M. Calcium-mediated cell death during myocardial reperfusion. Cardiovasc. Res. 2012, 94:168-180.
27. Sag C.M., Kohler A.C., Anderson M.E., Backs J., Maier L.S. CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes. J. Mol. Cell. Cardiol. 2011, 51:749-759.
28. Talukder M.A., Zweier J.L., Periasamy M. Targeting calcium transport in ischaemic heart disease. Cardiovasc. Res. 2009, 84:345-352.
29. Aurora A.B., Mahmoud A.I., Luo X., Johnson B.A., van Rooij E., Matsuzaki S., Humphries K.M., Hill J.A., Bassel-Duby R., Sadek H.A., Olson E.N. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death. J. Clin. Invest. 2012, 122:1222-1232.
30. Li R., Yan G., Li Q., Sun H., Hu Y., Sun J., Xu B. MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H(2)O(2))-induced apoptosis through targeting the mitochondria apoptotic pathway. PLoS One 2012, 7:e44907.